In an in vitro study, IL-21, in the presence of IL-2, enhanced the expansion of phosphoantigen-activated human Vγ9Vδ2 T cells and boosted their Th1-like program and cytotoxic activity against tumor cells [132]. The gene discussed is IL21; the disease is neoplasm.